Submitted by Anonymous (not verified) on 23 April 2024 - 11:59
Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Date of authorisation: 15/11/2021, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Date of authorisation: 15/11/2021, Revision: 6, Status: Authorised